Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors
- 29 February 1992
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 2 (1) , 15-20
- https://doi.org/10.1016/1050-1738(92)90039-u
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine, 1990
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Cigarette smoking: profiles of throm☐ane- and prostacyclin-derived products in human urineBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989
- Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in manBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Thromboxane Biosynthesis and Platelet Function in Type I Diabetes MellitusNew England Journal of Medicine, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Paired analysis of urinary thromboxane B2 metabolites in humansThrombosis Research, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Synthesis and structure of the platelet aggregation factor thromboxane A2Nature, 1985